This Article Full Text Full Text (PDF) All Versions of this Article: 35/2/e35    most recent 01.STR.0000113736.73632.F6v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Longatti, P.L. Articles by Carteri, A. Search for Related Content PubMed PubMed Citation Articles by Longatti, P.L. Articles by Carteri, A. Related Collections Cerebrovascular disease/stroke Ablation/ICD/surgery Acute Cerebral Hemorrhage Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Emergency treatment of Stroke Intracerebral Hemorrhage Other Stroke Treatment - Surgical

(Stroke. 2004;35:e35.)
© 2004 American Heart Association, Inc.

Research Reports

Neuroendoscopic Management of Intraventricular Hemorrhage

P.L. Longatti, MD; A. Martinuzzi, MD, PhD; A. Fiorindi, MD; L. Maistrello, MD A. Carteri, MD

From the Neurosurgery Unit, Department of Neuroscience, Treviso Hospital, Treviso (P.L.L., A.F., L.M., A.C.), and "E. Medea" Scientific Institute, Conegliano Research Centre, Conegliano (A.M.), Italy.

Correspondence to Andrea Martinuzzi, MD, PhD, "E. Medea" Scientific Institute, Conegliano Research Centre, Via Costa Alta 37, 31015 Conegliano (TV), Italy. E-mail andrea.martinuzzi{at}cn.lnf.it

Background and Purpose— We reviewed our 7-year experience in neuroendoscopic management of severe intraventricular hemorrhage (IVH) to evaluate its safety, efficiency, and efficacy.

Methods— Thirteen patients with spontaneous primary or secondary tetraventricular IVH underwent neuroendoscopy. In all procedures, we used a flexible instrument. CT scans obtained before and after surgery were compared for Graeb score and ventriculocranial ratio. Glasgow Outcome Scale was assessed at 12 months.

Results— In all patients, the procedure resulted in a substantial removal of ventricular blood. Graeb score was reduced by 65%, and ventriculocranial ratio was reduced by 30% (P<0.002). The procedure was carried out safely even in the presence of a vascular malformation, and no rebleeding or delayed hydrocephalus was observed in any case. Mortality at 12 months was 30.7%. Favorable outcome (Glasgow Outcome Scale, 3 to 5) was observed in 61.5% of cases.

Conclusions— Neuroendoscopic management of severe IVH in this cohort of patients was safe, efficiently reduced the amount of ventricular blood and ventricular dilatation, and effectively produced an outcome profile that compares very favorably with other more conventional treatments.

Key Words: endoscopy • intraventricular hemorrhage